Quantify IP's newest software, CPR, utilizes publicly available worldwide patent application and status data, and through newly developed proprietary processes, organizes it in new ways. This process allows any company's patent portfolio to be analyzed, and reports produced about not just your own company's patent portfolio, but even that of any competitor.
| Product | Mindshare (%) |
|---|---|
| Quantify IP Company Portfolios Revealed | 3.3% |
| Anaqua IAM | 17.2% |
| CPA Global | 15.9% |
| Other | 63.6% |
Discover where your company's patent costs can be trimmed or new markets that are underutilized. Or even uncover the filing patterns and costs expended by your competition on their patent portfolios. Save time and money, while acquiring new insights into your patent portfolio and gaining competitive intelligence not available before, all with the push of a button.
Quantify IP utilizes data licensed from the European Patent Office (EPO) for these analyses. The EPO has compiled and organized publication data from most countries' official patent offices. We license that data.
Exxon Mobil Global Services, Chevron, Johnson & Johnson, Caterpillar, Goodyear Tire & Rubber, 3M, Bridgestone/Firestone Inc, Pfizer,GE Healthcare, Unilever
We have not yet collected reviews for Quantify IP Company Portfolios Revealed. Share your experience with PeerSpot's community.
Share a review
